Position in ALKS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,338,851
+$659,884 QoQ
Shares Held
66,144
+10.2% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Federation des caisses Desjardins du Quebec holds $37,941,198 across 32 Drug Manufacturers - Specialty & Generic names. ALKS ranks #4 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
105,890 | $12,517,254 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
285,623 | $8,602,962 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
11,255 | $6,673,988 | |
| 4 | ALKS |
Alkermes plc.
This page
|
66,144 | $2,338,851 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
26,930 | $2,070,915 | |
| 6 | VTRS |
Viatris Inc
|
94,833 | $1,281,191 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
51,137 | $1,223,707 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
8,564 | $1,128,218 |
All Filings in ALKS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,338,851 | 66,144 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,678,967 | 60,006 | Shares | Defined | 2026-02-12 | |
| 2020-06-30 | $931 | 48 | Shares | Defined | 2024-08-30 | |
| 2020-03-31 | $692 | 48 | Shares | Defined | 2024-08-30 | |
| No filing history on record for this holder in this stock. | ||||||